News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Next Generation Sequencing (NGS) Kit to Improve Speed and Accuracy of M. Tuberculosis (MTB) Drug Sensitivity Testing (DST) at a Fraction of the Current Cost of Sequencing BETHESDA, Maryland, Sept. 25, 2018 /PRNewswire/ — Longhorn Vaccines and Diagnostics LLC (LHNVD), a private pre-analytical systems and molecular solutions company, is pleased to announce the validation of its newest technology,... Read more
Männedorf, Switzerland, September 3, 2018 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of NuGEN Technologies, Inc. (NuGEN) on August 31, 2018. On August 16, 2018, Tecan announced the acquisition of US-based NuGEN to further expand Tecan’s dedicated solutions offering into the new market segment of next-generation... Read more
–Custom NGS Panels for Illumina and Ion Torrent Platforms Use Paragon Genomics’ CleanPlex® Technology that Enables Interrogation of a Large Number of Targets in a Single Assay– –Complementary Expert Support Is Available to All Customers and Custom NGS Panels are Delivered in Just 2-4 Weeks– HAYWARD, Calif., Sept. 20, 2018 /PRNewswire/ — Paragon Genomics, Inc. today... Read more
Download PDF SAN FRANCISCO, Calif. – September 18, 2018 — Twist Bioscience issued the following statement: Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance. They omit that more than four months before it sought to change its... Read more
SANTA CRUZ, Calif., Sept. 18, 2018 /PRNewswire/ — SomaGenics, a biotechnology company focused on developing lowest bias sequencing and highest specificity RT-qPCR technologies for small RNAs, announced today the issue of US Patent 10,041,107, a continuation of SomaGenics’ patent family entitled “Methods and Compositions for Detection of small RNAs.” The new patent broads protection for SomaGenics’ innovative,... Read more
New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif., Sept. 18, 2018 /PRNewswire/ — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing... Read more
Location: Cambridge, UK 14/09/2018 AstraZeneca joins Horizon’s Genomics Discovery Initiative CRISPR knockout and activation libraries are a key toolset in early research crRNA libraries are an efficient and convenient platform for gain- and loss-of-function studies Cambridge, UK, 14 September 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene... Read more
MENLO PARK, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) — When creating a genomic ark of creatures great and small, scientists across the globe are turning to the comprehensive coverage and quality of long-read sequencing technology from Pacific Biosciences (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes.Today, the Vertebrate Genomes Project (VGP),... Read more
MENLO PARK, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) — When creating a genomic ark of creatures great and small, scientists across the globe are turning to the comprehensive coverage and quality of long-read sequencing technology from Pacific Biosciences (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes.Today, the Vertebrate Genomes Project (VGP),... Read more
September 11, 2018 Cambridge, Mass. and Athens, Greece., Sept 11, 2018. Seven Bridges, the leading biomedical data platform and analytics company, and e-NIOS, a biological knowledge discovery start-up, announced a strategic partnership towards data-driven discovery of biomarker signatures. Derivation of robust biomarkers from next generation sequencing and multi-omic data is currently a major bottleneck in precision medicine... Read more